Shandong Weigao Orthopaedic Device Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Shandong Weigao Orthopaedic Device's (SHSE:688161) Anemic Earnings Might Be Worse Than You Think
Nov 11
After Leaping 45% Shandong Weigao Orthopaedic Device Co., Ltd (SHSE:688161) Shares Are Not Flying Under The Radar
Oct 08Returns On Capital Signal Tricky Times Ahead For Shandong Weigao Orthopaedic Device (SHSE:688161)
Oct 04Shandong Weigao Orthopaedic Device Co., Ltd's (SHSE:688161) Popularity With Investors Is Clear
Aug 20Weak Statutory Earnings May Not Tell The Whole Story For Shandong Weigao Orthopaedic Device (SHSE:688161)
May 06CEO
Shandong Weigao Orthopaedic Device has no CEO, or we have no data on them.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 2yrs | CN¥120.00k | no data | |
| Director | 4.8yrs | no data | no data | |
| Independent Director | 4.8yrs | CN¥120.00k | no data | |
| Independent Director | 4.8yrs | CN¥120.00k | no data | |
| Chair of the Board | less than a year | no data | no data |
4.8yrs
Average Tenure
56yo
Average Age
Experienced Board: 688161's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 21:04 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shandong Weigao Orthopaedic Device Co., Ltd is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jian Jun Zou | Chasing Securities |
| Yiling Chen | Guosen Securities Co., Ltd. |
| Jiabo Zhang | Guosen Securities Co., Ltd. |